Laura Prendergast
Analyst
Stifel
Equibles does not estimate personal net worth.
About Laura Prendergast
Laura Prendergast is recorded as Analyst at Stifel. Laura Prendergast has spoken on 1 earnings call and 2 other investor events across 2 companies, most recently for Tango Therapeutics, Inc. on October 23, 2026. Those appearances were for Revolution Medicines, Inc. (RVMD) and Tango Therapeutics, Inc. (TNGX). The companies whose calls Laura Prendergast spoke on are classified in the Healthcare sector.
Laura Prendergast on recent calls
“Can you provide more color on the DDI, particularly as early to seemingly to act more at the level of bioavailability than clearance?”
“Can you speak to the inclusion of some first-line patients in RASOLUTE 302, you know, who didn't seem to do well in their, you know, adjuvant setting therapy, you know, their disposition at baseline, how they performed versus the second line patients enrolled, and, you know, to follow up on the last question, any…”
“I was curious, you know, what are some of the top variables still under consideration for diraxone RASIB in first-line lung cancer as far as strategy goes?”
Affiliation history
-
Stifel
Analyst
Source not stated
Current